Latest Trazodone Stories
New generation antidepressants, known as selective serotonin reuptake inhibitors (SSRIs) are associated with an increased risk of several severe adverse outcomes in older people compared with older tricyclic antidepressants (TCAs).
Scientists at the Fisher Center for Alzheimer's Disease Research at The Rockefeller University, led by Paul Greengard, Ph.D., and Jennifer Warner-Schmidt, Ph.D., have shown that anti-inflammatory drugs, which include ibuprofen, aspirin and naproxen, reduce the effectiveness of the most widely used class of antidepressant medications, the selective serotonin reuptake inhibitors, or SSRIs, taken for depression and obsessive-compulsive disorder and anxiety disorders.
PRINCETON, N.J., Jan. 25, 2011 /PRNewswire/ -- Angelini Labopharm, LLC, today confirmed Mary Anne Heino's appointment as President of the Company. Formerly Senior Vice President, Sales and Marketing for Labopharm Inc. and President of the company's wholly owned subsidiary, Labopharm USA, Inc., Ms.
- Company Advancing Partnership Discussions and Preparing for Canadian Launch - LAVAL, QC, Jan. 20 /PRNewswire/ - Labopharm Inc.
OLEPTROâ„¢ Data Presented at U.S. Psychiatric and Mental Health Congress OLEPTROâ„¢ Offers Physicians a Treatment Alternative for Patients with Major Depressive Disorder Princeton, NJ (Vocus) November 22, 2010 This week at the 2010 U.S.
Media Advisory ** Interview Opportunity Princeton, NJ (Vocus) November 18, 2010 Major depressive disorder (MDD) is a common mental illness that affects more than 14 million American adults.
LAVAL, QC, Nov. 12 /PRNewswire/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that on November 11, 2010 it received notice from Actavis South AtlanticÂ LLC advising that Actavis has submitted an Abbreviated New Drug Application (ANDA) to the U.S.
LAVAL, QC, Aug. 10 /PRNewswire-FirstCall/ - Labopharm Inc.
PRINCETON, N.J., Aug. 10 /PRNewswire/ -- Angelini Labopharm today announced that OLEPTRO(TM) (trazodone hydrochloride extended-release tablets), a novel once-daily formulation of the antidepressant trazodone, is now commercially available in the United States.
- an ornament or knob in the shape of a flower